These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16231980)

  • 21. Tenofovir helps prevent HIV in drug users.
    BMJ; 2013 Jun; 346():f3871. PubMed ID: 23777811
    [No Abstract]   [Full Text] [Related]  

  • 22. Tenofovir gel studied.
    AIDS Patient Care STDS; 2002 Aug; 16(8):401-2. PubMed ID: 12227991
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
    Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
    AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
    [No Abstract]   [Full Text] [Related]  

  • 24. The experts speak. Studying the potential of tenofovir to prevent sexual transmission of HIV: first steps. Interview by Vicki Glaser.
    Thompson M
    AIDS Patient Care STDS; 2005 Jan; 19(1):1-4. PubMed ID: 15665629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. We must not let protestors derail trials of pre-exposure prophylaxis for HIV.
    Lange JM
    PLoS Med; 2005 Sep; 2(9):e248. PubMed ID: 16008501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compassionate use for tenofovir.
    AIDS Patient Care STDS; 2000 Feb; 14(2):101-2. PubMed ID: 10743524
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-exposure prophylaxis for HIV infection: what if it works?
    Paxton LA; Hope T; Jaffe HW
    Lancet; 2007 Jul; 370(9581):89-93. PubMed ID: 17617276
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir].
    Harmouche H; Le Bras P; Bignani O; Delfraissy JF; Goujard C
    Rev Med Interne; 2005 Jun; 26(6):522-3. PubMed ID: 15936484
    [No Abstract]   [Full Text] [Related]  

  • 30. Cambodia stops important tenofovir prevention trial.
    James JS
    AIDS Treat News; 2004 Jul; (403):4-5. PubMed ID: 15386853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can the new humanized mouse model give HIV research a boost.
    Shacklett BL
    PLoS Med; 2008 Jan; 5(1):e13. PubMed ID: 18198940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenofovir trials raise ethical issues.
    Mills E
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):31-2. PubMed ID: 16365973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model.
    Rahman SM; Vaidya NK; Zou X
    J Theor Biol; 2014 Apr; 347():151-9. PubMed ID: 24380779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 35. Encouraging results for tenofovir.
    AIDS Patient Care STDS; 2001 May; 15(5):289. PubMed ID: 11530770
    [No Abstract]   [Full Text] [Related]  

  • 36. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 37. What they say about: nucleotide drugs.
    Posit Aware; 2000; 11(1):55. PubMed ID: 11366352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current data on antiretroviral therapy. CROI 2009: tenofovir DR convinces by high effectiveness and tolerance].
    Walter M
    MMW Fortschr Med; 2009 Apr; 151(18):76-9. PubMed ID: 19769084
    [No Abstract]   [Full Text] [Related]  

  • 39. Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys.
    Prescrire Int; 2014 May; 23(149):124-5. PubMed ID: 24926511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HIV agents. Trying times for tenofovir and abacavir.
    TreatmentUpdate; 2003 Oct; 15(6):2-3. PubMed ID: 17216860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.